DARE
Dare Bioscience Inc
NASDAQ: DARE · HEALTHCARE · BIOTECHNOLOGY
$2.28
+8.57% today
Updated 2026-04-30
Market cap
$30.72M
P/E ratio
—
P/S ratio
29.82x
EPS (TTM)
$-1.20
Dividend yield
—
52W range
$1 – $3
Volume
0.4M
Dare Bioscience Inc (DARE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-16.88M | $-21.00M | $-16.61M | $-19.06M | $-31.91M | $-33.54M | $-2.54M | $-10.27M | $-13.32M | $-25.23M | $-28.76M | $-18.09M | $-38.86M | $5.39M | $-9.89B |
| Capital expenditures | $219000.00 | $180000.00 | $7000.00 | $225000.00 | $277000.00 | $535000.00 | $11836.00 | $11836.00 | $17625.00 | $17625.00 | $14524.00 | $63069.00 | $629430.00 | $573046.00 | $385.28M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $529000.00 | $622000.00 | $885000.00 | $2.38M | $2.75M | $15832.00 | $139348.00 | $462239.00 | $742031.00 | $1.60M | $2.16M | $2.53M | $2.20M | $1.50B |
| Free cash flow | $-17.10M | $-21.18M | $-16.62M | $-19.29M | $-32.19M | $-34.07M | $-2.55M | $-10.28M | $-13.33M | $-25.25M | $-28.78M | $-18.15M | $-39.49M | $4.82M | $-10.27B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | $789.59M | $6.86M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $45.69M | $24.73M | $-40.96M | $7.52M | $-753957.00 | $-2.02M | $-121877.00 | — | — | — | — | — |